Compare · MEDP vs OABI
MEDP vs OABI
Side-by-side comparison of Medpace Holdings Inc. (MEDP) and OmniAb Inc. (OABI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MEDP and OABI operate in Biotechnology: Commercial Physical & Biological Resarch (Health Care), so they compete in similar markets.
- MEDP is the larger of the two at $13.08B, about 39.6x OABI ($330.5M).
- Over the past year, MEDP is up 53.6% and OABI is up 50.3% - MEDP leads by 3.3 points.
- MEDP has hit the wire 10 times in the past 4 weeks while OABI has been quiet.
- MEDP has more recent analyst coverage (25 ratings vs 5 for OABI).
- Company
- Medpace Holdings Inc.
- OmniAb Inc.
- Price
- $457.81+0.76%
- $2.27-8.28%
- Market cap
- $13.08B
- $330.5M
- 1M return
- +6.68%
- +54.95%
- 1Y return
- +53.60%
- +50.33%
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 2021
- News (4w)
- 10
- 0
- Recent ratings
- 25
- 5
Medpace Holdings Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Latest MEDP
- New insider Hansman Brad W. claimed ownership of 697 shares (SEC Form 3)
- SEC Form 8-K filed by Medpace Holdings Inc.
- General Counsel & Corp. Secy. Ewald Stephen P exercised 16,349 shares at a strike of $138.87 and sold $7,357,050 worth of shares (16,349 units at $450.00) (SEC Form 4)
- SEC Form 8-K filed by Medpace Holdings Inc.
- SEC Form 4 filed by Director Zander Dani S.
- SEC Form 4 filed by Director Mccarthy Cornelius P. Iii
- SEC Form 4 filed by Director Kraft Robert O.
- SEC Form 4 filed by Director Gwadry-Sridhar Femida H.
- SEC Form 4 filed by Director Davenport Fred B Jr
- SEC Form 4 filed by Director Carley Brian T
Latest OABI
- SEC Form 10-Q filed by OmniAb Inc.
- OmniAb Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- OmniAb Reports First Quarter 2026 Financial Results and Business Highlights
- SEC Form DEF 14A filed by OmniAb Inc.
- SEC Form DEFA14A filed by OmniAb Inc.
- OmniAb to Participate in Three Upcoming Investor Conferences
- SEC Form 4 filed by Gotwals Philip J
- SEC Form 4 filed by Crouse Steven C.
- OmniAb to Report First Quarter 2026 Financial Results on May 7
- SEC Form 144 filed by OmniAb Inc.